APP and Alzheimer disease: Similar mechanism may be involved in young, pre-depositing APP transgenic mice which developed cerebral β-amyloidosis and associated pathology after being intracerebrally injected with Aβ-containing brain extracts from human patients with AD (Meyer-Luehmann et al., 2006; Langer et al., 2011).